Google
×
Oramed has an experienced management team with many years of business and pharmaceutical experience, and is backed by world-class scientific experts. Learn More.
Learn More. Edit Content. 03. Investors. Learn More. ORMP. $2.92. Oramed Pharmaceuticals Inc. 3.55%. Volume$208.24K. Market cap$118.32M. Corporate presentation.
People also ask
According to Zacks Investment Research, based on 1 analysts' forecasts, the consensus EPS forecast for the quarter is $0.02. The reported EPS for the same ...
Find the latest Oramed Pharmaceuticals Inc. Common Stock (ORMP) annual income statements, balance sheets, financial statements, ratios, and cash flow data ...
Find the latest Oramed Pharmaceuticals Inc. (ORMP) stock quote, history, news and other vital information to help you with your stock trading and investing.
Missing: relations | Show results with:relations
Oramed Pharmaceuticals Inc. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. View ORMP financial statements in full.
Missing: relations | Show results with:relations
Get Oramed Pharmaceuticals Inc (ORMP.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.
Missing: relations | Show results with:relations
Oramed Pharmaceuticals Inc. is currently listed on NASDAQ under ORMP. One share of ORMP stock can currently be purchased for approximately $2.83. Is Oramed ...
Missing: relations | Show results with:relations
Rating (975)
Oramed Pharmaceuticals (ORMP) is schdueled to report earning on Jul 10, 2024, TBA Not Confirmed. What is Oramed Pharmaceuticals (ORMP) earnings time?
Missing: relations | Show results with:relations
(NasdaqCM:ORMP) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size.